Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
NCT01009515
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
19
Enrollment
OTHER
Sponsor class
Stopped
Low accrual; target accrual not met
Conditions
Melanoma
Interventions
DRUG:
Paclitaxel, carboplatin, temozolomide
Sponsor
New Mexico Cancer Research Alliance